Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Points to Consider When Managing Inflammatory Arthritis with Cancer

RheumNow

J. Cush

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Safety and Monitoring Considerations in Systematic Therapy

Masterclasses in Dermatology

J. Cohen

Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

Imaging Considerations for the Dermatologist

Masterclasses in Dermatology

C. Bakewell

Cancer and IBD

Boston University Chobanian & Avedisian School of Medicine

F. A. Farraye

Challenging Case: A Patient with Comorbid Solid Organ Malignancy

International Psoriasis Council (IPC)

M. Angeliki Gkini

Challenges of Prevention and Treatment of COVID-19 in the Immunocomp…

Cleveland Clinic Rheumatology

C. Calabrese

Comorbidities of Psoriasis and PsA

Masterclasses in Dermatology

J. Cohen

Comparing the Safety and Effectiveness of Methotrexate, TNF and IL6 …

Anne Bass

EADV 2023 Insights: Generalized Pustular Psoriasis: Current and Futu…

EADV 2023 Insights

M. Elsamahy

An Overview of Atypical Ulcers

EADV 2022 Conference Coverage

K. Isoherranen

Anorectal Disease for the General Internist

Michigan Medicine

R. Burney

Dermatological Disorders and COVID-19

Cleveland Clinic Rheumatology

J. M. Gelfand

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

RheumNow

J. Cush

Medical Therapy Related Complications in IBD

Cedars Sinai

M. Long

Association Between Inflammatory Bowel Disease and Prostate Cancer

Northwestern Medicine Gastroenterology

S. D. Kundu

COVID-19 and the Risks From Immunomodulatory Therapies

Cleveland Clinic Rheumatology

Z. Wallace

SARS-CoV-2 Vaccine Cutaneous Side Effects and Immunosuppressants

Keck School of Medicine of USC

B. Ngo